Carsten Thiel Understands The Science of Molecules and Marketing

 

Carsten Thiel holds a Ph.D. in molecular biology from the Max Planck Institute. Thiel left his native Germany to study organic and biochemistry at the University of Bristol in England earning a Bachelor’s in biochemistry. Even though he is a scientist by training Carsten Thiel has a knack for sales and marketing.

Hoffman La-Roche

Thiel’s first job after college was with the Basel, Switzerland based biotechnology company Hoffman La-Roche. His first post at Hoffman La-Roche was Communications and Product Manager. For Carsten Thiel, his time with Hoffman La-Roche was both a learning and employment opportunity. Carsten Thiel gained knowledge in the areas of research and development, customer service, and marketing.

Xenical

Xenical is the prescription version of the over-the-counter weight loss drug Alli. Xenical works by inhibiting the absorption of fat. To realize maximum results Xenical has to be taken as part of a diet and exercise regimen. When Hoffman La-Roche was ready to bring Xenical to market Carsten Thiel was charged with overseeing the marketing of Xenical. See This Page for additional information.

Carsten Thiel’s Strategy

There is a tendency to rush a new product to market with much hoopla and a touch of puffery. Carsten Thiel took a different approach to promote Xenical. Hoffman La-Roche would not depend on exaggerated promises to sell Xenical. Carsten Thiel focused on identifying the drug’s target market. Specifically, Thiel wanted prescribers to recommend Xenical to patients, who were most likely to make the lifestyle changes necessary to achieve maximum success with the drug. Prescriber and consumer education also factored into Thiel’s marketing strategy.

Success

Carsten Thiel’s tactics were designed to slowly establish a positive reputation for Xenical. The slow and steady approach to marketing the drug paid-off. In its first year on the market, Swiss sales of Xenical equaled 1 billion francs.

 

Additional reference: https://www.prnewswire.com/news-releases/eusa-pharma-announces-appointment-of-carsten-thiel-as-president-europe-and-darrel-p-cohen-as-head-of-clinical-development-300850275.html

 

Carsten Thiel Takes Time With Family Before Business

 

Carsten Thiel had been surrounded by science and medicine since he was a child. As the son of medical doctors, he had always wanted to follow the footsteps of his parents and work in some part of medicine.

Thiel is now an expert in pharmaceuticals and biopharmaceuticals who has helped launch many different successful products throughout his career.

He was raised in Germany in a time that was still turbulent before he moved to the U.K. in order to pursue an education at the University of Bristol. While he was attending the school, he earned his bachelors and master’s degrees in organic chemistry and biochemistry. He went on to earn a Ph.D. from Max Planck Institute for Biophysical Chemistry for Molecular Biology.

Taking time out of his day to spend time with family is important for Carsten Thiel. Because his days can sometimes get quite busy and long, he makes sure to spend the mornings with them discussing their lives over breakfast and coffee. This is a good time to be able to get everyone’s schedule synched while relaxing before he starts his day. After spending time with his family, he reads the news and checks his emails. He stated that these activities are important and he tries to do them every day. Go To This Page to learn more.

It’s easy to become overwhelmed by everything that you need to do during your day which is why Carsten Thiel tries to prioritize. By making sure that Carsten Thiel is keeping his long-term goals in mind instead of just his short term, he is better able to accomplish what needs to be done. In addition, building relationships is important to any business which is why he spends another good part of his day communicating with customers and meeting with the board of the company to make sure everyone has the same goals.

 

Like him on https://www.facebook.com/carsten.thiel.58

Carsten Thiel And Darrel P. Cohen Join EUSA Pharma

Dr. Carsten Thiel was recently appointed to the office of President of EUSA Pharma in Europe. Dr. Darrel P Cohen was also appointed as Head of EUSA’s Clinical Development Department.

EUSA is a company that focuses on creating pharmaceuticals that treat rare diseases. Both Dr. Cohen and Dr. Thiel have extensive educations and experience to fill these positions and strengthen EUSA’s structure globally in clinical development.

Carsten Thiel attended the University of Marburg and has a Masters in Biochemistry as well as a PhD in Molecular Biology from Max Planck Institute in Germany. Dr. Thiel started his career at Hoffman La Roche. He held several positions at Amgen.

During his time at Amgen, Dr. Thiel was responsible for the development of several products that treated bone disorders, nephrology, and oncology. Carsten Thiel followed this up with a few years working for Alexion Pharmaceuticals Inc. and prior to his position at EUSA Europe Dr. Thiel held the position of CEO at Abeona Therapeutics focusing on US gene-based therapies.

Darrel P. Cohen attended the Boston University School of Medicine where he obtained an MD and a PhD in Microbiology. He has held the position of Director for Clinical research for Sanofi- Aventis. Dr. Cohen previously led the Clinical Development Center of Pfizer’s global oncology as Vice president and was responsible for helping in the development of several oncology products that were quite successful. In his long career, Dr. Darrel P. Cohen has held the positions of Associate in Medicine and Hematology/ Oncology fellow at the Duke University Medical Center. Dr. Darrel P. Cohen brings 20 years of experience as a hematologist/oncologist in clinical development to EUSA. Go To This Page to learn more.

 

Learn more about Thiel on https://uk.linkedin.com/in/carsten-thiel-8970b45